SUBSCRIBE
Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2011, Vol. 9 ›› Issue (12): 1353-1359.doi: 10.3736/jcim20111212

• Original Experimental Research • Previous Articles     Next Articles

Medicated serum prepared with Chinese herbal medicine Zhizhen Recipe down-regulates activity of nuclear factor-κB and expression of P-glycoprotein in human colorectal cancer multidrug-resistant cell line HCT-8/VCR

Song-bai Cai, Xu Zhang, Zhi-xia Chen, Ling-chun Kong, Song-po Wang()   

  1. Department of Traditional Chinese Medicine, Shanghai First People's Hospital, Shanghai Jiao Tong University, Shanghai 200080, China
  • Received:2011-08-15 Accepted:2011-09-05 Online:2011-12-20 Published:2011-12-15

RichHTML

3

PDF (PC)

72

Like

Objective: To investigate the effects of medicated serum prepared with Chinese herbal medicine Zhizhen Recipe (ZZR) on activity of nuclear factor-κB (NF-κB) and expression and function of P-glycoprotein (P-gp) in human colorectal cancer multidrug-resistant cell line HCT-8/VCR.
Methods: The multidrug resistance of HCT-8/VCR cells was detected by cell counting kit-8 method, and the experimental concentrations of ZZR-medicated serum were determined by the same way. HCT-8 and HCT-8/VCR cells were treated with ZZR-medicated serum of medium dose for 24 h. The activity of NF-κB was determined by enzyme-linked immunosorbent assay. The intracellular distribution of P-gp was detected by laser scanning confocal microscopy, and the mean fluorescence intensity of rhodamine 123 was detected by flow cytometry.
Results: ZZR-medicated sera with volume fraction of 8%, 16% and 32% of medium dose were confirmed as the experimental sera. Compared with the untreated group, NF-κB activities of the ZZR-medicated serum groups (ZZR-medicated serum with volume fraction of 8%, 16% and 32% of medium dose) were obviously down-regulated (P<0.01), which had a negative correlation with the concentrations. After interfering HCT-8/VCR with ZZR-medicated serum of different concentrations for 24 h, P-gp in HCT-8/VCR transmitted gradually from cell membrane to cytoplasm and nuclei. Nuclei became pyknotic and cracking. Compared with the untreated group, the mean fluorescence intensities of ZZR-medicated serum groups declined with concentration gradients (P<0.01). The efflux of intracellular rhodamine 123 decreased, the wave crest shifted to right, and the intracellular fluorescence intensity strengthened (P<0.01).
Conclusion: ZZR-medicated sera of experimental concentrations down-regulate activity of NF-κB and expression and function of P-gp in human colorectal cancer multidrug-resistant cell line HCT-8/VCR and the effect is related to the concentrations.

Key words: colorectal neoplasms, P-glycoprotein, NF-kappa B, compound (traditional Chinese drugs)

Table 1

Sensitivity of HCT-8 and HCT-8/VCR cells to different chemotherapeutic drugs (x±s)"

Drug n IC50 (μg/mL)
HCT-8 HCT-8/VCR Resistance index of HCT-8/VCR (%)
VCR 3 0.14±0.02 9.55±0.23** 70.74
5-FU 3 3.19±0.34 65.71±0.26** 20.60
CDDP 3 0.74±0.04 4.13±0.16** 5.58
EP 3 0.80±0.07 3.79±0.12** 4.74

Table 2

Inhibition rates of HCT-8/VCR cell line treated with different concentrations of medicated serum"

Group n Inhibition rate at different concentrations of medicated serum
2% 4% 8% 16% 32% 64%
Blank serum 3 1.24±0.31 3.56±0.01 2.14±0.02 2.77±0.05 3.43±0.05 3.35±0.08
Low-dose medicated serum 3 0 7.42±0.03 12.91±1.68△△ 11.19±1.15△△ 10.59±2.07△△ 41.10±1.02△△
Medium-dose medicated serum 3 1.61±1.12 11.03±1.31 20.11±1.83△△ 23.70±1.61△△ 24.75±2.86△△ 43.89±3.28△△
High-dose medicated serum 3 1.43±0.07 9.45±0.04 16.24±1.04△△ 21.32±1.59△△ 30.29±3.46△△ 57.71±3.69△△

Table 3

NF-κB activity in HCT-8/VCR cell line treated with medicated serum for 24 h (x±s)"

Group n Absorbance value at 450 nm
HCT-8 3 3.534±0.120*
HCT-8/VCR 3 3.863±0.055
Blank serum 3 3.923±0.125
8% Medicated serum 3 3.457±0.091△△
16% Medicated serum 3 2.946±0.066△△
32% Medicated serum 3 2.868±0.079△△
BAY11-7082 3 2.730±0.042△△

Figure 1

Distribution of P-gp in HCT-8 and HCT-8/VCR cell lines treated with different concentrations of medicated serum (Laser scanning confocal microscopy, ×2 400) A: HCT-8; B: HCT-8/VCR; C: Blank serum; D: 8% Medicated serum; E: 16% Medicated serum; F: 32% Medicated serum; G: BAY11-7082. P-gp: P-glycoprotein."

Table 4

Mean fluorescence intensity of P-gp in cells treated with different concentrations of medicated serum"

Group n Mean flourence intensity
HCT-8 3 33.175±3.735
HCT-8/VCR 3 133.015±6.548
Blank serum 3 134.090±10.400
8% Medicated serum 3 43.148±3.236△△
16% Medicated serum 3 25.840±2.640△△
32% Medicated serum 3 23.448±3.302△△
BAY11-7082 3 8.625±4.406△△

Table 5

Efflux function of P-gp in cells treated with different concentrations of medicated serum"

Group n Mean flourence intensity
HCT-8 3 100.00
HCT-8/VCR 3 24.82±12.07
Blank serum 3 26.31±1.04
8% Medicated serum 3 186.76±40.42△△
16% Medicated serum 3 245.78±10.09△△
32% Medicated serum 3 282.31±77.53△△
BAY11-7082 3 321.69±20.36△△

Figure 2

Efflux function of P-gp in cells treated with different concentrations of medicated serum A: HCT-8; B: HCT-8/VCR; C: Blank serum; D: 8% Medicated serum; E: 16% Medicated serum; F: 32% Medicated serum; G: BAY11-7082. P-gp: P-glycoprotein."

[1] Luo XQ, Yang GW . Research progress on traditional Chinese medicine treatment of gastric cancer. Yi Xue Zong Shu. 2009; 15(18): 2835-2838. Chinese with abstract in English.
罗晓琴, 杨国旺 . 中医药治疗胃癌的研究进展.医学综述. 2009; 15(18):2835-2838.
[2] Xu SY, Bian RL, Chen X. Methodology of pharmacological experiment. Beijing: People’s Medical Publishing House. 1982: 202-204. Chinese.
徐叔云, 卞如濂, 陈修 . 药理实验方法学.北京: 人民卫生出版社. 1982: 202-204.
[3] Feller N, Kuiper CM, Lankelma J, Ruhdal JK, Scheper RJ, Pinedo HM, Broxterman HJ . Functional detection of MDR1/P170 and MRP/P19〇-mediated multidrug resistance in tumour cells by flow cytometry[J]. Br Cancer. 1995; 72(3) : 543-549.
doi: 10.1038/bjc.1995.371
[4] Haimeur A, Conseil G, Deeley RG, Cole SP . The MRP-related and BCRP/ABCG2 multidrug resistance proteins : biology, substrate specificity and regulation. Curr Drug Metab. 2005; 5(1):21-53.
[5] Yeh JJ, Hsu NY, Hsu WH, Tsai CH, Lin CC, Liang JA . Comparison of chemotherapy response with P- glycoprotein, multidrug resistance-related protein-1, and lung resistance-related protein expression in untreated small cell lung cancer. Lung. 2005 ; 183(3):177-183.
doi: 10.1007/s00408-004-2532-1
[6] Berney DM, Shamash J, Gaffney J, Jordan S, Oliver RT . DNA topoisomerase I and E expression in drug resistant germ cell tumours[J]. Br Cancer. 2002 ; 87(6):624-629.
doi: 10.1038/sj.bjc.6600472 pmid: 2364243
[7] Notarbartolo M, Cervello M, Dusonchet L, Cusimano A, D’Alessandro N . Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins). Cancer Lett. 2002 ; 180(1) : 91-101.
doi: 10.1016/S0304-3835(01)00834-5
[8] Queiroz KC, Ruela-de-Sousa RR, Fuhler GM, Aberson HL, Ferreira CV, Peppelenbosch MP, Spek CA . Hedgehog signaling maintains chemoresistance in myeloid leukemic cells. Oncogene. 2010; 29(48):6314-6322.
doi: 10.1038/onc.2010.375 pmid: 20802532
[9] Hayden MS, Ghosh S . Shared principles in NF-icB signaling. Cell. 2008; 132(3):344-362.
doi: 10.1016/j.cell.2008.01.020
[10] Bentires-Alj M, Barbu V, Fillet M, Chariot A, Relic B, Jacobs N, Gielen J, Merville MP, Bours V . NF-icB transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene. 2003; 22(1):90-97.
doi: 10.1038/sj.onc.1206056
[11] Bourguignon LY, Xia W, Wong G . Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates p-catenin signaling and NFicfrspecific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells.[J] Biol Chem. 2009 ; 284(5):2657-2671.
doi: 10.1074/jbc.M806708200
[12] Zhang JK, Wang ZY, Ding DP, Xin Y . Effect of Astragulus injection on chemosensitivity of drug-resistant hepatic carcinoma Bel/Fu cell line. Zhongguo Zhong Xi Yi Jie He Wai Ke Za Zhi. 2008; 14(4): 398-402. Chinese with abstract in English.
doi: 10.3969/j.issn.1007-6948.2008.04.039
张隽开, 王忠裕, 丁大朋, 辛毅 . 黄芪对肝癌耐药细胞株Bel/Fu化疗敏感性的影响.中国中西医结合外科杂志. 2008; 14(4):398-402.
doi: 10.3969/j.issn.1007-6948.2008.04.039
[1] Mu-yan Kong, Le-yan Li, Yan-mei Lou, Hong-yu Chi, Jin-jun Wu. Chinese herbal medicines for prevention and treatment of colorectal cancer: from molecular mechanisms to potential clinical applications. Journal of Integrative Medicine, 2020, 18(5): 369-384.
[2] Li Tao, Ying-jie Zhu , Xian-mei Lu , Ying Gu , Ai-guang Zhao , Jian Zheng, Chuan-gang Fu, Jin-kun Yang. Clinical study on survival benefit for elderly patients with resected stage I or E colorectal cancer based on traditional Chinese medicine syndrome differentiation and treatment. Journal of Chinese Integrative Medicine, 2010, 8(12): 1159-1164.
[3] Qing Lin , Jian Zheng, Si Ai, Li-xing Lin, Yu-xin Chen, Fang Wang, Ling Zhu . Mechanism of combined treatment with Shenkangling Decoction and prednisone in rats with adriamycin-induced nephropathy. Journal of Chinese Integrative Medicine, 2009, 7(7): 661-666.
[4] Ju-yong Wang , Ye Jin, Zhen-ye Xu, Zhan Zheng. Effects of Feiyanning Decoction on gene expression of nuclear factor-κB activated by tumor necrosis factor-α in lung adenocarcinoma cell line. Journal of Chinese Integrative Medicine, 2009, 7(3): 249-254.
[5] Gong-jian Dai, Hei-ying Jin, Yi-jiang Ding, Jian-guo Xia, Xiu-fang Liu, Fei Liu, Xuan-zhong Tan, Jian-xiang Geng. Anticancer effects of tea polyphenols on colorectal cancer with microsatellite instability in nude mice. Journal of Chinese Integrative Medicine, 2008, 6(12): 1263-1266.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] Dong Yang, Yong-ping Du, Qing Shen, Wei Chen, Yan Yu, Guang-lei Chen. Expression of alpha-smooth muscle actin in renal tubulointerstitium in patients with kidney collateral stasis. Journal of Chinese Integrative Medicine, 2008, 6(1): 41-44
[2] Hai-feng Wei, Bai-liu Ya, Ling Zhao, Cui-fei Ye, Li Zhang, Lin Li. Evaluation of tongue manifestation of blood stasis syndrome and its relationship with blood rheological disorder in a rat model of transient brain ischemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 73-76
[3] Xi Lin, Jian-ping Liu. Herbal medicines for viral myocarditis. Journal of Chinese Integrative Medicine, 2008, 6(1): 76
[4] Xi Lin, Jian-ping Liu. Tai chi for treating rheumatoid arthritis. Journal of Chinese Integrative Medicine, 2008, 6(1): 82
[5] Liang-ping Hu, Hui Gao. Discrimination of errors in statistical analysis of medical papers published in the first issue of 2006 in Journal of Chinese Integrative Medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 98-106
[6] Yan-bo Zhu , Qi Wang, Cheng-yu Wu, Guo-ming Pang, Jian-xiong Zhao, Shi-lin Shen, Zhong-yuan Xia , Xue Yan . Logistic regression analysis on relationships between traditional Chinese medicine constitutional types and overweight or obesity. Journal of Chinese Integrative Medicine, 2010, 8(11): 1023-1035
[7] Wei Xu, Meng Shi, Jian-gang Liu, Cheng-long Wang . Collagen protein expressions in ischemic myocardium of rats with acute myocardial infarction and effects of qi-tonifying, yin-tonifying and blood-activating herbs and detoxifying and blood-activating herbs. Journal of Chinese Integrative Medicine, 2010, 8(11): 1041-1047
[8] Tao Wang , Feng Qin. Effects of Chinese herbal medicine Xiaoyao Powder on monoamine neurotransmitters in hippocampus of rats with postpartum depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1075-1079
[9] Ying Xu , Chang-chun Zeng , Xiu-yu Cai , Rong-ping Guo , Guang Nie , Ying Jin. Chromaticity and optical spectrum colorimetry of the tongue color in different syndromes of primary hepatic carcinoma. Journal of Chinese Integrative Medicine, 2012, 10(11): 1263-1271
[10] Xiang-ying Mao , Qin Bian , Zi-yin Shen. Analysis of the osteogenetic effects exerted on mesenchymal stem cell strain C3H10T1/2 by icariin via MAPK signaling pathway in vitro. Journal of Chinese Integrative Medicine, 2012, 10(11): 1272-1278
Journal of Integrative Medicine, ISSN: 2095-4964 CN 31-2083/R
Copyright © Journal of Integrative Medicine
Powered by Beijing Magtech Co. Ltd
沪公网安备31010602003416号      沪ICP备18017633号-3